Skip to content
Market Tracked raises in 2026$3.41B+$183M this week Rounds76 LatestBlue J$176M Series E Wednesday, November 11

JuryTalk

JuryTalk helps trial teams build live seating charts, capture collaborative juror notes, surface patterns, and make better jury selection decisions in the moment.

Parambil

Parambil is AI medical record review software for mass tort and complex litigation.

JuryTalk vs Parambil

At a Glance

DetailJuryTalkParambil
CategoryeDiscoveryeDiscovery
Total raisedNot disclosed$8M
Rounds trackedNot disclosed2
Latest roundNot disclosedSeed, $6M · Jan 2026
Last valuationNot disclosedNot disclosed
Lead investorsNot disclosedBling Capital, Daybreak Ventures
Built forNot disclosedMid-size firms, Boutiques
HeadquartersNot disclosedUnited States

Funding, Side by Side

JuryTalkUndisclosed
Parambil$8M
JuryTalk rounds

No public rounds tracked yet.

Parambil rounds
  1. Jan 2026Seed$6M
  2. Jan 2025Seed$2M

Our Take

We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.

Quick Answers

Which has raised more, JuryTalk or Parambil?
Parambil has raised $8M in disclosed funding, compared with no disclosed amount for JuryTalk.
What is JuryTalk best for?
JuryTalk helps trial teams build live seating charts, capture collaborative juror notes, surface patterns, and make better jury selection decisions in the moment.
What is Parambil best for?
Parambil is AI medical record review software for mass tort and complex litigation.

Source: Legal Tech Circle funding data, from public announcements. Updated November 11, 2026.